基于PDX模型的神经母细胞瘤临床耐药机制动态研究
81572918
2015
H1821.肿瘤治疗抵抗
吴晔明
面上项目
主任医师
上海交通大学
52万元
蛋白质组学;耐药;化疗;C25_其它肿瘤;人源肿瘤组织异种移植模型
2016-01-01到2019-12-31
- 中英文摘要
- 结题摘要
- 结题报告
- 项目成果
- 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
| 序号 | 标题 | 类型 | 作者 |
|---|---|---|---|
| 1 | Both serum and tissue Galectin-1 levels are associated with adverse clinical features in neuroblastoma | 期刊论文 | Chen K;Cai Y;Zhang M;Wu ZX;Wu YM |
| 2 | Annexin A2 could enhance multidrug resistance by regulating NF-kappaB signaling pathway in pediatric neuroblastoma | 期刊论文 | Wang Y.;Chen K.;Cai Y.;Cai Y.;Yuan X.;Wang L.;Wu Z.;Wu Y. |
| 3 | Legumain correlates with neuroblastoma differentiation and can be used in prodrug design. | 期刊论文 | Zhang Min;Jiang Zhiteng;Chen Sheng;Wu Zhixiang;Chen Kai;Wu Yeming |
| 4 | 15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo | 期刊论文 | Cai Y.;Lv F.;Kaldybayeva N.;Zhamilya A.;Wu Z.;Wu Y. |
| 5 | The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation | 期刊论文 | Gu;Y.;Lv;F.;Xue;M.;Chen;K.;Cheng;C.;Ding;X.;Jin;M.;Xu;G.;Zhang;Y.;Wu;Z.;Zheng;L.;Wu;Y. |
查看更多信息请先登录或注册
趋势报告
